| MDL | MFCD00904759 |
|---|---|
| Molecular Weight | 464.72 |
| Molecular Formula | C28H40N4S |
| SMILES | CC(C)C1=CC(C(C)C)=C(C2=CSC(=N2)N(CCN(C)C)CC2=CC=CN=C2)C(=C1)C(C)C |
Foropafant (SR27417) highly potent, competitive, selective and orally active antagonist of platelet-activating factor ( PAF ) receptor, with a K i value of 57 pM for [ 3 H]PAF binding, at least 5-fold lower than that of unlabeled PAF itself. Foropafant potently inhibits PAF-induced aggregation of rabbit and human platelets [1] .
Ki: 57 pM ([ 3 H]PAF binding) [1]
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 100 mg/mL ( 215.18 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.1518 mL | 10.7592 mL | 21.5183 mL |
| 5 mM | 0.4304 mL | 2.1518 mL | 4.3037 mL |
| 10 mM | 0.2152 mL | 1.0759 mL | 2.1518 mL |